Skip to main content
Regeneron Pharmaceuticals, Inc. (REGN)
NASDAQ: REGN · Real-Time Price · USD
718.36
-4.44 (-0.61%)
At close: Dec 5, 2025, 4:00 PM EST
721.00
+2.64 (0.37%)
After-hours: Dec 5, 2025, 7:45 PM EST

Regeneron Pharmaceuticals Revenue by Segment
Period Ending Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020
Collaboration
6.97B 6.66B 6.32B 6.06B 5.82B 5.60B 5.39B 5.50B
Collaboration Growth
19.69% 18.93% 17.26% 10.08% 1.76% 4.99% 6.56% 11.99%
Net Product
6.64B 7.00B 7.28B 7.63B 7.48B 7.32B 7.17B 7.08B
Net Product Growth
-11.24% -4.40% 1.57% 7.79% 7.98% 5.43% 3.59% 2.67%
Other
643.20M 559.40M 480.00M 515.00M 548.10M 572.20M 537.00M 536.10M
Other Growth
17.35% -2.24% -10.61% -3.94% 21.45% 44.06% 38.72% 46.84%
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.